Eptifibatide, is an antiplatelet drug of the glycoprotein IIb/IIIa inhibitor class. Eptifibatide is a cyclic heptapeptide derived from a protein found in the venom of the southeastern pygmy rattlesnake (Sistrurus miliarius barbouri). It belongs to the class of the so-called RGD (arginine-glycine-aspartate)-mimetics and reversibly binds to platelets. We provide Eptifibatide Acetate. More information please visit the website:https://www.creative-peptides.com/product/eptifibatide-acetate-item-10-101-15-48.html
Creative peptides is specialized in the process development and the manufacturing of bioactive peptides. We offer custom peptide synthesis, process development, GMP manufacturing as well as catalog products.The products in our catalog peptides without a stated purity are unconditionally guaranteed to be a minimum of 95% by HPLC. Each product will be shipped with a HPLC,MS, and COA.Creative peptides offers custom peptide services using a unique portfolio of specific technologies. We have profound...
View more >>
Basic Information
Business Type: Manufacturer
Product/Service (We Buy): 51 - 100 People
Ownership Type: Individual (Sole proprietorship)
Registered Capital: US$501 Thousand - US$1 Million
Year Established: 2005
Number of Employees: 51 - 100 People
Trade & Market
Main Markets: North America,Southeast Asia,Mid East,South America,Africa,Eastern Asia,Eastern Europe,Oceania,Western Europe
QA/QC: 0
Number of R&D Staff: 0
Total Annual Sales Volume: US$10 Million - US$50 Million